有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Anagrelide hydrochloride;BMY-26538-01;BL-4162A;Xagrid;Agrylin;Agrelin
Chemical Name 6,7-Dichloro-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-one hydrochloride;6,7-Dichloro-3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one hydrochloride;6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one hydrochloride
CAS 58579-51-4
Related CAS 68475-42-3 (free base)
Formula C10H8Cl3N3O
Structure
Formula Weight 292.55376
Stage 上市-1997
Company Inverni della Beffa (Orphan Drug), Kirin Brewery (Orphan Drug), Shire Pharmaceuticals (Orphan Drug), Shire BioChem (Originator), Shire Pharmaceuticals (Originator), Inverni della Beffa (Licensee), Kirin Brewery (Licensee), Yuhan (Licensee)
Activity/Mechanism Antithrombocythemic, HEMATOLOGIC DRUGS, Hematopoiesis Disorders Therapy, Phosphodiesterase III Inhibitors
Syn. Route 4
Route 1
the nitration of 1,2,3-trichlorobenzene (i) with concentrated hno3 gives 2,3,4-trichloronitrobenzene (ii), which by reaction with cuprous cyanide in hot pyridine is converted to 2,3-dichloro-6-nitrobenzonitrile (iii). the reduction of (iii) with borane in thf yields 2,3-dichloro-6-nitrobenzylamine (iv), which by reaction with ethyl bromoacetate (v) by means of triethylamine in refluxing dioxane affords ethyl n-(2,3-dichloro-6-nitrobenzyl)glycinate (vi). the reduction of (vi) with sncl2 in concentrated hcl gives ethyl n-(6-amino-2,3-dichlorobenzyl)glycinate (vii), which is cyclized with cyanogen bromide (viii) in toluene affording ethyl 5,6-dichloro-3,4-dihydro-2-(1h)-iminoquinazoline-3-acetate (ix). finally, this compound is submitted to a new cyclization by means of triethylamine in refluxing ethanol.
List of intermediates No.
[(2r,3s,4s,5r)-5-(6-amino-2-fluoro-9h-purin-9-yl)-3,4-dihydroxytetrahydro-2-furanyl]methyl diethyl phosphate (v)
potassium (9z,12z)-9,12-octadecadienoate (viii)
tert-butyl(dimethyl)[2-[(2r,3s)-3-methyl-6-methylenetetrahydro-2h-pyran-2-yl]ethoxy]silane; tert-butyl(dimethyl)silyl 2-[(2r,3s)-3-methyl-6-methylenetetrahydro-2h-pyran-2-yl]ethyl ether (i)
(z)-2-butyl-2-butenal (ii)
tert-butyl(dimethyl)silyl 2-[(2r,3s,6s)-9-butyl-3-methyl-1,7-dioxaspiro[5.5]undec-8-en-2-yl]ethyl ether; tert-butyl[2-[(2r,3s,6s)-9-butyl-3-methyl-1,7-dioxaspiro[5.5]undec-8-en-2-yl]ethoxy]dimethylsilane (iii)
(iv)
(2r,5s,7r,8s)-2-butyl-7-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-8-methyl-1,6-dioxaspiro[4.5]decane-2-carbaldehyde (vi)
(1r)-1-[(2r,5s,7r,8s)-2-butyl-7-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-8-methyl-1,6-dioxaspiro[4.5]dec-2-yl]-3-(trimethylsilyl)-2-propyn-1-ol (vii)
1-[(2r,5s,7r,8s)-2-butyl-7-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-8-methyl-1,6-dioxaspiro[4.5]dec-2-yl]-3-(trimethylsilyl)-2-propyn-1-one (ix)
Reference 1:
    jenks, t.a.; beverung, w.n.jr.; partyka, r.a. (bristol-myers squibb co.); preparation of 6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3h)-one. ca 1137474 .

Route 2
the reaction of 3-chloroaniline (x) with choral hydrate (xi) and hydroxylamine gives isonitroso-3-chloroacetanilide (xii), which is cyclized by means of h2so4 to 4-chloroisatin (xiii). chlorination of (xiii) with so2cl2 affords 4,5-dichloroisatin (xiv), which is oxidized with h2o2 yielding 5,6-dichloroanthranilic acid (xv). the reduction of (xv) with borane in thf gives 6-amino-2,3-dichlorobenzyl alcohol (xvi), which by reaction with socl2 in benzene is converted to 6-amino-2,3-dichlorobenzyl chloride (xvii). this compound is condensed with ethyl glycinate (xviii) by means of triethylamine in refluxing methylene chloride to give ethyl n-(6-amino-2,3-dichlorobenzyl)glycinate (vii), which is cyclized with cyanogen bromide (viii) in toluene affording ethyl 5,6-dichloro-3,4-dihydro-2-(1h)-iminoquinazoline-3-acetate (ix). finally, this compound is submitted to a new cyclization by means of triethylamine in refluxing ethanol.
List of intermediates No.
1-methoxy-2-naphthaldehyde (xviii)
(3r)-3-(dicyclobutylamino)-8-fluoro-3,4-dihydro-2h-chromene-5-carboxylic acid (xi)
(3r)-6-bromo-3-(dicyclobutylamino)-8-fluoro-3,4-dihydro-2h-chromene-5-carbonyl chloride (x)
potassium (9z,12z)-9,12-octadecadienoate (viii)
(1r)-1-[(2r,5s,7r,8s)-2-butyl-7-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-8-methyl-1,6-dioxaspiro[4.5]dec-2-yl]-3-(trimethylsilyl)-2-propyn-1-ol (vii)
1-[(2r,5s,7r,8s)-2-butyl-7-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-8-methyl-1,6-dioxaspiro[4.5]dec-2-yl]-3-(trimethylsilyl)-2-propyn-1-one (ix)
(1s)-1-[(2r,5s,7r,8s)-2-butyl-7-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-8-methyl-1,6-dioxaspiro[4.5]dec-2-yl]-3-(trimethylsilyl)-2-propyn-1-ol (xii)
(1s)-1-[(2r,5s,7r,8s)-2-butyl-7-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-8-methyl-1,6-dioxaspiro[4.5]dec-2-yl]-2-propyn-1-ol (xiii)
(1s)-1-[(2r,5s,7r,8s)-2-butyl-7-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-8-methyl-1,6-dioxaspiro[4.5]dec-2-yl]-2-propynyl tert-butyl(dimethyl)silyl ether; tert-butyl([(1s)-1-[(2r,5s,7r,8s)-2-butyl-7-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-8-methyl-1,6-dioxaspiro[4.5]dec-2-yl]-2-propynyl]oxy)dimethylsilane (xiv)
2-[(2r,5s,7r,8s)-2-butyl-2-((1s)-1-[[tert-butyl(dimethyl)silyl]oxy]-2-propynyl)-8-methyl-1,6-dioxaspiro[4.5]dec-7-yl]-1-ethanol (xv)
2-[(2r,5s,7r,8s)-2-butyl-2-((1s)-1-[[tert-butyl(dimethyl)silyl]oxy]-2-propynyl)-8-methyl-1,6-dioxaspiro[4.5]dec-7-yl]acetaldehyde (xvi)
(e)-4-[(2r,5s,7r,8s)-2-butyl-2-((1s)-1-[[tert-butyl(dimethyl)silyl]oxy]-2-propynyl)-8-methyl-1,6-dioxaspiro[4.5]dec-7-yl]-2-methyl-2-butenal (xvii)
Reference 1:
    jenks, t.a.; beverung, w.n.jr.; partyka, r.a. (bristol-myers squibb co.); preparation of 6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3h)-one. ca 1137474 .

Route 3
the condensation of 2-nitro-6-chlorobenzyl chloride (i) with ethyl glycinate (ii) by means of triethylamine in refluxing ethanol gives ethyl n-(2-nitro-6-chlorobenzyl)glycinate (iii), which is reduced with h2 over pd/c in ethanol yielding ethyl n-(2-amino-6-chlorobenzyl)glycinate (iv). the cyclization of (iv) with cyanogen bromide (a) in refluxing ethanol affords 6-chloro-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-one (v), which is finally chlorinated with cl2 and fecl3 in hot nitromethane.
List of intermediates No.
1-methoxy-2-naphthaldehyde (ii)
potassium (9z,12z)-9,12-octadecadienoate (a)
(2r,3r)-2-(2,4-difluorophenyl)-1-(1h-1,2,4-triazol-1-yl)-2,3-butanediol (i)
1-[[(2s,3s)-2-(2,4-difluorophenyl)-3-methyloxiranyl]methyl]-1h-1,2,4-triazole (iii)
(2r,3r)-2-(2,4-difluorophenyl)-3-(methylsulfanyl)-1-(1h-1,2,4-triazol-1-yl)-2-butanol (iv)
(2r,3r)-2-(2,4-difluorophenyl)-3-(methylsulfanyl)-1-(1h-1,2,4-triazol-1-yl)-2-butanol (v)
Reference 1:
    beverung, w.n.jr.; partyka, a.; optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(h)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones. us 3932407 .
Reference 2:
    castaner, j.; serradell, m.n.; hillier, k.; blancafort, p.; anagrelide hydrochloride. drugs fut 1980, 5, 3, 117.

Route 4
the nitration of 2,3-dichlorobenzaldehyde (i) with hno3/h2so4 gives 2,3-dichloro-6-nitrobenzaldehyde (ii), which is reduced with nabh4 in methanol, yielding 2,3-dichloro-6-nitrobenzyl alcohol (iii). the reaction of (iii) with socl2 and tea affords the benzyl chloride (iv), which is condensed with glycine ethyl ester (v) by means of tea to provide the adduct (vi). the reduction of the nitro group of (vi) with sncl2 in aq. hcl or h2 over pto2/c in ethanol gives the expected amino derivative (vii), which is cyclized with cn-br in toluene to yield the iminoquinazoline (viii). finally, this compound is further cyclized by means of tea in water to afford the target imidazoquinazolinone.
List of intermediates No.
1-methoxy-2-naphthaldehyde (v)
tert-butyl (1s)-1-[[(2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)oxy]carbonyl]-2-methylpropylcarbamate (i)
(2r,5s,7r,8s)-2-butyl-7-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-8-methyl-1,6-dioxaspiro[4.5]decane-2-carbaldehyde (vi)
(1r)-1-[(2r,5s,7r,8s)-2-butyl-7-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-8-methyl-1,6-dioxaspiro[4.5]dec-2-yl]-3-(trimethylsilyl)-2-propyn-1-ol (vii)
1-[(2r,5s,7r,8s)-2-butyl-7-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)-8-methyl-1,6-dioxaspiro[4.5]dec-2-yl]-3-(trimethylsilyl)-2-propyn-1-one (viii)
Reference 1:
    lang, p.c.; spencer, r.p.; yeh, w.-l.; roth, m.j. (shire richwood inc.); method for the manufacture of anagrelide. wo 0208228 .

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名盐酸阿那格雷;英文名Anagrelide hydrochloride;BMY-26538-01;BL-4162A;Xagrid;Agrylin;Agrelin;CAS[58579-51-4]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
北京富安凯科技有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
江苏地区粗苯价格暂稳
山东地区粗苯价格暂稳
华东地区丁二烯市场弱势盘整
浙江省化学农药使用量连续7年持
华东地区丁二烯市场价格走低
兴发集团实现草甘膦副产物高效高
华北地区BDO市场弱势延续
我国化工园区第一个国家标准已获
华南地区己二酸行情持稳
浙江地区二氯甲烷价格暂稳
红太阳/丰山集团等8家农药生产
刘学:浅析农药登记后再评价工作
中国农民礼赞!——写在第一个“
2018年智能制造试点示范项目
2018年秋播小麦种子药剂处理
内蒙古元正精细化工高效氟吡甲禾
南京高正/江苏耕耘/江西正邦等
江西地区二氯甲烷价格暂稳
山东地区二氯甲烷市场价格上调
噻虫嗪比吡虫啉更适合小麦拌种
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明